The growing need for processing natural lipophilic and often volatile substances such as thymol, a promising candidate for topical treatment of intestinal mucosa, led us to the utilization of solid-state nuclear magnetic resonance (ss-NMR) spectroscopy for the rational design of enteric pellets with a thymol self-emulsifying system (SES). The SES (triacylglycerol, Labrasol®, and propylene glycol) provided a stable o/w emulsion with particle size between 1 and 7 µm. The ex vivo experiment confirmed the SES mucosal permeation and thymol delivery to enterocytes. Pellets W90 (MCC, Neusilin®US2, chitosan) were prepared using distilled water (90 g) by the M1−M3 extrusion/spheronisation methods varying in steps number and/or cumulative time. The pellets (705−740 µm) showed mostly comparable properties—zero friability, low intraparticular porosity (0−0.71%), and relatively high density (1.43−1.45%). They exhibited similar thymol release for 6 h (burst effect in 15th min ca. 60%), but its content increased (30−39.6 mg/g) with a shorter process time. The M3-W90 fluid-bed coated pellets (Eudragit®L) prevented undesirable thymol release in stomach conditions (<10% for 3 h). A detailed, ss-NMR investigation revealed structural differences across samples prepared by M1−M3 methods concerning system stability and internal interactions. The suggested formulation and methodology are promising for other lipophilic volatiles in treating intestinal diseases.

Department of NMR Spectroscopy Institute of Macromolecular Chemistry Czech Academy of Sciences 162 06 Prague Czech Republic

Department of Pharmaceutical Technology Faculty of Pharmacy Masaryk University Brno 612 00 Brno Czech Republic

Department of Pharmacology and Toxicology Veterinary Research Institute 621 00 Brno Czech Republic

Zobrazit více v PubMed

Javed H., Meeran M.F.N., Jha N.K., Ojha S. Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19. Front. Plant Sci. 2021;11:601335. doi: 10.3389/fpls.2020.601335. PubMed DOI PMC

Kumar A., Choudhir G., Shukla S.K., Sharma M., Tyagi P., Bhushan A., Rathore M. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J. Biomol. Struct. Dyn. 2020;39:3760–3770. doi: 10.1080/07391102.2020.1772112. PubMed DOI PMC

Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160:99–114.e3. doi: 10.1053/j.gastro.2020.04.014. PubMed DOI

Pithadia A.B., Jain S. Treatment of inflammatory bowel disease (IBD) Pharmacol. Rep. 2011;63:629–642. doi: 10.1016/S1734-1140(11)70575-8. PubMed DOI

Chan W., Chen A., Tiao D., Selinger C., Leong R. Medication adherence in inflammatory bowel disease. Intest. Res. 2017;15:434–445. doi: 10.5217/ir.2017.15.4.434. PubMed DOI PMC

Marchese A., Orhan I.E., Daglia M., Barbieri R., Di Lorenzo A., Nabavi S.F., Gortzi O., Izadi M., Nabavi S.M. Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem. 2016;210:402–414. doi: 10.1016/j.foodchem.2016.04.111. PubMed DOI

Nabavi S.M., Marchese A., Izadi M., Curti V., Daglia M., Nabavi S.F. Plants belonging to the genus Thymus as antibacterial agents: From farm to pharmacy. Food Chem. 2015;173:339–347. doi: 10.1016/j.foodchem.2014.10.042. PubMed DOI

Chamanara M., Abdollahi A., Rezayat S.M., Ghazi-Khansari M., Dehpour A., Nassireslami E., Rashidian A. Thymol reduces acetic acid-induced inflammatory response through inhibition of NF-kB signaling pathway in rat colon tissue. Inflammopharmacology. 2019;27:1275–1283. doi: 10.1007/s10787-019-00583-8. PubMed DOI

Liu D.-M., Zhou C.-Y., Meng X.-L., Wang P., Li W. Thymol exerts anti-inflammatory effect in dextran sulfate sodium-induced experimental murine colitis. Trop. J. Pharm. Res. 2018;17:1803. doi: 10.4314/tjpr.v17i9.18. DOI

Van Noten N., Degroote J., Van Liefferinge E., Taminiau B., De Smet S., Desmet T., Michiels J. Effects of Thymol and Thymol α-D-Glucopyranoside on Intestinal Function and Microbiota of Weaned Pigs. Animals. 2020;10:329. doi: 10.3390/ani10020329. PubMed DOI PMC

Tahmasebi P., Abtahi Froushani S.M., Afzale Ahangaran N. Thymol has beneficial effects on the experimental model of ulcerative colitis. Avicenna J. Phytomed. 2019;9:538–550. doi: 10.22038/AJP.2019.13383. PubMed DOI PMC

Lorenzo J.M., Khaneghah A.M., Gavahian M., Marszałek K., Es I., Munekata P.E.S., Ferreira I.C.F.R., Barba F.J. Understanding the potential benefits of thyme and its derived products for food industry and consumer health: From extraction of value-added compounds to the evaluation of bioaccessibility, bioavailability, anti-inflammatory, and antimicrobial activities. Crit. Rev. Food Sci. Nutr. 2018;59:2879–2895. doi: 10.1080/10408398.2018.1477730. PubMed DOI

Salehi B., Mishra A.P., Shukla I., Sharifi-Rad M., del Mar Contreras M., Segura-Carretero A., Fathi H., Nasrabadi N.N., Kobarfard F., Sharifi-Rad J. Thymol, thyme, and other plant sources: Health and Potential Uses: Thymol, Health and Potential Uses. Phytother. Res. 2018;32:1688–1706. doi: 10.1002/ptr.6109. PubMed DOI

Kohlert C., Schindler G., März R., Abel G., Brinkhaus B., Derendorf H., Gräfe E.-U., Veit M. Systemic Availability and Pharmacokinetics of Thymol in Humans. J. Clin. Pharmacol. 2002;42:731–737. doi: 10.1177/009127002401102678. PubMed DOI

Meeran M.F.N., Javed H., Al Taee H., Azimullah S., Ojha S.K. Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development. Front. Pharmacol. 2017;8:380. doi: 10.3389/fphar.2017.00380. PubMed DOI PMC

Sahu R.K., Khan J. Formulation strategies to improve the bioavailability of poorly absorbed drugs. Adv. Chall. Pharm. Technol. Mater. Process Dev. Drug Deliv. Strateg. 2021;2013:229–242. doi: 10.1016/b978-0-12-820043-8.00009-8. DOI

Abdulkarim M., Sharma P.K., Gumbleton M. Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies. Adv. Drug Deliv. Rev. 2019;142:62–74. doi: 10.1016/j.addr.2019.04.001. PubMed DOI

Nikolakakis I., Partheniadis I. Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release. Pharmaceutics. 2017;9:50. doi: 10.3390/pharmaceutics9040050. PubMed DOI PMC

Serratoni M., Newton M., Booth S., Clarke A. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur. J. Pharm. Biopharm. 2007;65:94–98. doi: 10.1016/j.ejpb.2006.07.011. PubMed DOI

Rassu G., Nieddu M., Bosi P., Trevisi P., Colombo M., Priori D., Manconi P., Giunchedi P., Gavini E., Boatto G. Encapsulation and modified-release of thymol from oral microparticles as adjuvant or substitute to current medications. Phytomedicine. 2014;21:1627–1632. doi: 10.1016/j.phymed.2014.07.017. PubMed DOI

Muley S., Nandgude T., Poddar S. Extrusion–spheronization a promising pelletization technique: In-depth review. Asian J. Pharm. Sci. 2016;11:684–699. doi: 10.1016/j.ajps.2016.08.001. DOI

Krupa A., Jachowicz R., Kurek M., Figiel W., Kwiecień M. Preparation of solid self-emulsifying drug delivery systems using magnesium aluminometasilicates and fluid-bed coating process. Powder Technol. 2014;266:329–339. doi: 10.1016/j.powtec.2014.06.043. DOI

Brus J., Albrecht W., Lehmann F., Geier J., Czernek J., Urbanova M., Kobera L., Jegorov A. Exploring the Molecular-Level Architecture of the Active Compounds in Liquisolid Drug Delivery Systems Based on Mesoporous Silica Particles: Old Tricks for New Challenges. Mol. Pharm. 2017;14:2070–2078. doi: 10.1021/acs.molpharmaceut.7b00167. PubMed DOI

Urbanova M., Pavelkova M., Czernek J., Kubova K., Vyslouzil J., Pechova A., Molinkova D., Vyslouzil J., Vetchy D., Brus J. Interaction Pathways and Structure–Chemical Transformations of Alginate Gels in Physiological Environments. Biomacromolecules. 2019;20:4158–4170. doi: 10.1021/acs.biomac.9b01052. PubMed DOI

Policianova O., Brus J., Hruby M., Urbanova M., Zhigunov A., Kredatusova J., Kobera L. Structural Diversity of Solid Dispersions of Acetylsalicylic Acid As Seen by Solid-State NMR. Mol. Pharm. 2014;11:516–530. doi: 10.1021/mp400495h. PubMed DOI

Geppi M., Mollica G., Borsacchi S., Veracini C.A. Solid-State NMR Studies of Pharmaceutical Systems. Appl. Spectrosc. Rev. 2008;43:202–302. doi: 10.1080/05704920801944338. DOI

Jang J.-H., Jeong S.-H., Lee Y.-B. Enhanced Lymphatic Delivery of Methotrexate Using W/O/W Nanoemulsion: In Vitro Characterization and Pharmacokinetic Study. Pharmaceutics. 2020;12:978. doi: 10.3390/pharmaceutics12100978. PubMed DOI PMC

Merchant H.A., McConnell E.L., Liu F., Ramaswamy C., Kulkarni R.P., Basit A.W., Murdan S. Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. Eur. J. Pharm. Sci. 2011;42:3–10. doi: 10.1016/j.ejps.2010.09.019. PubMed DOI

Pavoni J.M.F., Luchese C.L., Tessaro I.C. Impact of acid type for chitosan dissolution on the characteristics and biodegradability of cornstarch/chitosan based films. Int. J. Biol. Macromol. 2019;138:693–703. doi: 10.1016/j.ijbiomac.2019.07.089. PubMed DOI

Steckel H., Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur. J. Pharm. Biopharm. 2003;57:107–114. doi: 10.1016/S0939-6411(03)00156-5. PubMed DOI

Boyandin A.N., Dvoinina L.M., Sukovatyi A.G., Sukhanova A.A. Production of Porous Films Based on Biodegradable Polyesters by the Casting Solution Technique Using a Co-Soluble Porogen (Camphor) Polymers. 2020;12:1950. doi: 10.3390/polym12091950. PubMed DOI PMC

Koizumi K.-I., Watanabe Y., Morita K., Utoguchi N., Matsumoto M. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int. J. Pharm. 1997;152:127–131. doi: 10.1016/S0378-5173(97)04924-7. DOI

Al-Khattawi A., Mohammed A.-U. Compressed orally disintegrating tablets: Excipients evolution and formulation strategies. Expert Opin. Drug Deliv. 2013;10:651–663. doi: 10.1517/17425247.2013.769955. PubMed DOI

Zhou M., Wang Y., Wu F., Shen L., Lin X., Feng Y. Development on porous particles of Pueraria lobatae Radix for improving its compactibility and dissolution. RSC Adv. 2018;8:24250–24260. doi: 10.1039/C8RA04125C. PubMed DOI PMC

Baranauskaite J., Ockun M.A., Uner B., Tas C., Ivanauskas L. Effect of the Amount of Polysorbate 80 and Oregano Essential Oil on the Emulsion Stability and Characterization Properties of Sodium Alginate Microcapsules. Molecules. 2021;26:6304. doi: 10.3390/molecules26206304. PubMed DOI PMC

Bechgaard H., Ladefoged K. Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J. Pharm. Pharmacol. 1978;30:690–692. doi: 10.1111/j.2042-7158.1978.tb13366.x. PubMed DOI

Clarke G., Newton J., Short M. Gastrointestinal transit of pellets of differing size and density. Int. J. Pharm. 1993;100:81–92. doi: 10.1016/0378-5173(93)90078-T. DOI

Tuleu C., Andrieux C., Boy P., Chaumeil J. Gastrointestinal transit of pellets in rats: Effect of size and density. Int. J. Pharm. 1999;180:123–131. doi: 10.1016/S0378-5173(98)00400-1. PubMed DOI

Vertomrnen J., Kinget R. The Influence of Five Selected Processing and Formulation Variables on the Particle Size, Particle Size Distribution, and Friability of Pellets Produced in a Rotary Processor. Drug Dev. Ind. Pharm. 1997;23:39–46. doi: 10.3109/03639049709148480. DOI

Yang S.T., Van Savage G., Weiss J., Ghebre-Sellassie I. The effect of spray mode and chamber geometry of fluid-bed coating equipment and other parameters on an aqueous-based ethylcellulose coating. Int. J. Pharm. 1992;86:247–257. doi: 10.1016/0378-5173(92)90203-E. DOI

Zheng B., Zhang X., Peng S., McClements D.J. Impact of curcumin delivery system format on bioaccessibility: Nanocrystals, Nanoemulsion droplets, and natural oil bodies. Food Funct. 2019;10:4339–4349. doi: 10.1039/C8FO02510J. PubMed DOI

Charoenthai N., Kleinebudde P., Puttipipatkhachorn S. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose. AAPS PharmSciTech. 2007;8:E99–E109. doi: 10.1208/pt0803064. PubMed DOI

Nilsen-Nygaard J., Strand S.P., Vårum K.M., Draget K.I., Nordgård C.T. Chitosan: Gels and Interfacial Properties. Polymers. 2015;7:552–579. doi: 10.3390/polym7030552. DOI

Muselík J., Komersová A., Kubová K., Matzick K., Skalická B. A Critical Overview of FDA and EMA Statistical Methods to Compare In Vitro Drug Dissolution Profiles of Pharmaceutical Products. Pharmaceutics. 2021;13:1703. doi: 10.3390/pharmaceutics13101703. PubMed DOI PMC

Mullarney M.P., Beach L.E., Dave R., Langdon B.A., Polizzi M., Blackwood D.O. Applying dry powder coatings to pharmaceutical powders using a comil for improving powder flow and bulk density. Powder Technol. 2011;212:397–402. doi: 10.1016/j.powtec.2011.06.008. DOI

Goh H.P., Heng P.W.S., Liew C.V. Comparative evaluation of powder flow parameters with reference to particle size and shape. Int. J. Pharm. 2018;547:133–141. doi: 10.1016/j.ijpharm.2018.05.059. PubMed DOI

Zhao Y., Wang C., Chow A.H.L., Ren K., Gong T., Zhang Z., Zheng Y. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies. Int. J. Pharm. 2010;383:170–177. doi: 10.1016/j.ijpharm.2009.08.035. PubMed DOI

Pedro A.S., Santo I.E., Silva C.V., Detoni C., Albuquerque E. The Use of Nanotechnology as an Approach for Essential Oil-Based Formulations with Antimicrobial Activity. In: Méndez-Vilas A., editor. Microbial Pathogens and Strategies for Combating Them: Science, Technology and Education. 4th ed. Formatex; Badajoz, Spain: 2013. pp. 1364–1374.

Ujilestari T., Dono N.D., Ariyadi B., Martien R., Zuprizal Z. Formulation and characterization of self-nano emulsifying drug delivery systems of lemongrass (cymbopogon citratus) essential oil. Malays. J. Fundam. Appl. Sci. 2018;14:360–363. doi: 10.11113/mjfas.v14n3.1070. DOI

Bruce L.D., Koleng J.J., Mcginity J.W. The Influence of Polymeric Subcoats and Pellet Formulation on the Release of Chlorpheniramine Maleate from Enteric Coated Pellets. Drug Dev. Ind. Pharm. 2003;29:909–924. doi: 10.1081/DDC-120024187. PubMed DOI

Zhu Z., Min T., Zhang X., Wen Y. Microencapsulation of Thymol in Poly(lactide-co-glycolide) (PLGA): Physical and Antibacterial Properties. Materials. 2019;12:1133. doi: 10.3390/ma12071133. PubMed DOI PMC

Long M., Chen Y. Dissolution Testing of Solid Products. In: Qiu Y., Chen Y., Zhang G., Yu L., Mantri R.V., editors. Developing Solid Oral Dosage Forms. 2nd ed. Academic Press; Cambridge, UK: 2009. pp. 319–340. DOI

Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm. Res. 1995;12:413–420. doi: 10.1023/A:1016212804288. PubMed DOI

Park S.-H., Choi H.-K. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Int. J. Pharm. 2006;321:35–41. doi: 10.1016/j.ijpharm.2006.05.004. PubMed DOI

Pharma Excipients. [(accessed on 20 June 2022)]. Available online: https://www.pharmaexcipients.com/wp-content/uploads/2020/05/Technical-Data-Sheet_Neusilin-US2_Pharma.pdf.

Moine L., Canali M., Porporatto C., Correa S. Reviewing the biological activity of chitosan in the mucosa: Focus on intestinal immunity. Int. J. Biol. Macromol. 2021;189:324–334. doi: 10.1016/j.ijbiomac.2021.08.098. PubMed DOI